MedMen Enters Massachusetts’ Thriving Cannabis Market
MedMen Enters Massachusetts’ Thriving Cannabis Market MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced the opening of its newest store location in Boston’s famed Fenway Park area....
With Colombia on the Rise is PharmaCielo Stock a Buy?
In an increasingly globalized cannabis market, Colombia continues to make headlines. In fact, this July, Colombian President Ivan Duque gave the Colombian cannabis industry a huge bump by signing a directive to allow for the export of dried cannabis flower. Several...
Open Book Extracts Continues Global Expansion
Open Book Extracts Continues Global Expansion With demand increasing for quality, high purity cannabinoid ingredients and finished goods globally, leading cannabinoid-based health and wellness producer, Open Book Extracts (OBX), has expanded operations with the...
Resonate Blends: What Cannabis Stocks Investors Should Know
California-based cannabis holding company, Resonate Blends, is valued at a market cap of $16.56 million. Resonate is currently pre-revenue and uses plant-based ingredients such as cannabinoids, terpenes and other herbs with medicinal properties to produce wellness...
USA Medical: How an American CBD Company Became Successful in Europe
USA Medical: How an American Company Became Successful in Europe. From within the fresh-air mountains of Colorado comes USA Medical’s organic, GMO-free hemp – the foundation of their globally loved hemp extract CBD oil and CBD capsules. But how did this...
CanninPlus with Trading Alerts!
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 7-day trial.
Still unsure? Schedule demo at [email protected]
or call 720-254-1374
The Best Cannabis Stocks for 2022
-
Cannin Report Q2 2021
$49.00
-
Cannin Report Q1 2021
$29.00
-
The Cannin Report 2020
$19.00
-
FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick
$0.00
-
The Cannin Report Q4 2019
$29.00
